Counterfeit Drugs
Bristol-Myers Squibb is committed to ensuring the safety and integrity of its products as part of its pledge to extend and enhance human life.
Counterfeit drugs represent a threat to the Bristol-Myers Squibb pledge to provide our customers with the safest, most effective and highest quality products. The World Health Organization estimates that up to 10 percent of medications consumed globally are counterfeit or substandard, putting patient safety at significant risk. There is no single solution to this issue; however, Bristol-Myers Squibb has efforts in place to help ensure the integrity of our products and further patient safety:
- An integrated team addresses counterfeiting issues
- Product security technology to make our packaging and products less vulnerable to counterfeiting
- Participation in industry coalitions and organizations addressing this issue
- Collaboration with supply chain vendors and law enforcement agencies on product security matters
Counterfeit Drugs and Travel
U.S. Food and Drug Administration
Partnership for Safe Medicines
Buy Safe Drugs
IMPACT! International Medical Products Anti-Counterfeiting Taskforce